The best stocks to buy since 1993

Latest issue now available


September 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • TET
  • Price:
  • 544p
Treatt has been a stellar performer since I made  it a main buy at 217.5p in Nov ‘16, having touched £13 since then. But this month saw the high flying shares come back with a bit of a bump after Treatt said H2 profitability would fall short of expectations, although sales will still be higher than last year’s £124m. There is no single factor for the downgrade and it is more of a margin issue than sales performance with the two main reasons cited as a weaker performance in the tea category and FX volatility. In FY21, the group had seen a very strong tea revenue performance (+113%), which is one of its higher margin lines. This has not repeated this year, as US consumer demand in the category has reduced, and also some new product l ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X



To access our archive of articles and to receive current issues you need to subscribe